FIELD: biotechnology.
SUBSTANCE: group of inventions is described, including a compound represented by formula (I) or a pharmaceutically acceptable salt thereof
(I),
the use of a compound represented by formula (I) or a pharmaceutically acceptable salt thereof in the preparation of drugs or kits for the prevention, alleviation or treatment of neurodegenerative diseases, depression or seizure, the use of a compound represented by formula (I) or a pharmaceutically acceptable salt thereof in the preparation of compositions, kits or kits for reducing the suppression of neuroinflammation, the use of a compound represented by formula (I) or a pharmaceutically acceptable salt thereof in the preparation of compositions, kits or kits for promoting the production of neural progenitor cells, the use of a compound represented by formula (I) or a pharmaceutically acceptable salt thereof in the preparation of compositions, kits or kits to reduce the production of Aβ, a pharmaceutical composition for preventing, alleviating, or treating Alzheimer's disease; and a method for preventing, alleviating, or treating neurodegenerative diseases, depression caused by a neurodegenerative disease, or an attack of a neurodegenerative disease.
EFFECT: invention expands the arsenal of means for the prevention, alleviation or treatment of neurodegenerative diseases.
4 cl, 10 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC DRUG FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND ITS USE | 2019 |
|
RU2799454C2 |
| CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION | 2014 |
|
RU2665709C2 |
| CONDENSED AZA-HETEROCYCLIC AMIDE COMPOUND AND ITS USE | 2021 |
|
RU2811975C1 |
| N-(2-THIAZOLYL)AMIDE DERIVATIVES AS GSK-3 INHIBITORS | 2007 |
|
RU2429237C2 |
| PYRIDOPYRIMIDINE COMPOUND, METHOD FOR PRODUCTION, PHARMACEUTICAL COMPOSITION AND APPLICATION OF INDICATED COMPOUNDS | 2014 |
|
RU2662713C2 |
| N-(2-THIAZOLYL)AMIDE DERIVATIVES AS GSK-3 INHIBITORS | 2007 |
|
RU2450000C2 |
| QUINOLINE COMPOUNDS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF AS MEDICINAL AGENT WHICH INHIBITS URATE TRANSPORTER | 2016 |
|
RU2715229C2 |
| IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2696275C1 |
| CHEMICAL COMPOUNDS AS INTERLEUKIN-1 INHIBITORS | 2018 |
|
RU2792143C2 |
| COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2383545C2 |
